1Banat GA,Beatty GL,Paterson Y,et al.Tumor-induced suppression of immune response and its correction.Cancer Immunol Immunother,2001,49:473-586.
2Schadendorf C,Belordelli F,Ferrantini M,et al.Conference on cancer vaccines.J Immunother,2000,49:281-284.
3Tuteja R.DNA vaccines:a ray of hope.Crit Rev Biochem Mol Biol,1999,34(1):1-24.
4Rakhmilevich AL,Imboden M,Hao Z,et al.Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding Gp 100 and granulocyte-macrophage colony-stimulating factor.Clin Cancer Res,2001,7(4):952-961.
5Ross HM,Weber LW,Wang S,et al.Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization.Clin Cancer Res,1997,3(12):2191-2196.
6Xiang R,Silletti S,Lode HN,et al.Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice.Clin Cancer Res,2001,7(3 Suppl):856-864.
7Ohashi T,Hanabuchi S,Kato H,et al.Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine.J Virol,2000,74(20):9610-9616.
8Geissler M,Wands G,Gesien A,et al.Genetic immunization with the free human chorionic gonadotropin beta subunit elicits cytotoxic T lymphocyte responses and protects against tumor formation in mice.Lab Invest,1997,76(6):859-871.
9Bhattachary R,Bukkapatnam R,Prawoko,et al.Efficacy of vaccination with plasmid DNA encoding for HER2/neu or HER2/neu-eGFP fusion protein against prostate cancer in rats.Int Immuno Pharmacol,2002,2(6):783-796.
10Kontani K,Taguchi O,Ozaki Y,et al.Novel vaccination protocol consisting of injecting MUC1 DNA and nonprimed dendritic cells at the same region greatly enhanced MUC1-specific antitumor immunity in a murine model.Cancer Gene Ther,2002,9(4):330-337.
8El-Gabalawy HS,Lipsky PE.Why do we not have a cure for rheumatoid arthritis? The scientific basis of rheumatology.Arthritis Res,2002,4 (suppl.3):s297 -s301.
9Paul Carter.Improving the efficacy of antibody-based cancer therapies.Nature Review (cancer),2001,Nov(1):118-129.
10Coiffier B.Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma.N Engl J Med,2002,346,235.
